3 reports

  • Impact of drivers and challenges
  • Introduction

About Migraines A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men owing to the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs,...

  • Antimigraine
  • Allergan plc
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • SMALL MOLECULE TO INHIBIT GABA TRANSAMINASE FOR MIGRAINE AND STATUS EPILEPTICUS - DRUG PROFILE
  • DIHYDROERGOTAMINE - DRUG PROFILE

Migraine - Overview Migraine - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MIGRAINE, H## 2017 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MIGRAINE, H## 2017 Pre-Registration ## ## Filing rejected/ Withdrawn ## ## Phase III ## ## Phase II ## ## Phase I ## ## P

  • Antimigraine
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • BOTOX Migraine Sales by Geography in US$ Million, 2012-2017

Most people experience more than one phase.

  • Antimigraine
  • World
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.